A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. - Fleischmann RM; Bliddal H; Blanco FJ; Schnitzer TJ; Peterfy C; Chen S; Wang L; Feng S; Conaghan PG; Berenbaum F; Pelletier JP; Martel-Pelletier J; et al. (Arthritis & rheumatology (Hoboken, N.J.), 2019)